Related content

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

By Duffour Jacqueline   Gourgou Sophie   Desseigne Françoise   Debrigode Charles   Mineur Laurent   Pinguet Frédéric   Poujol Sylvain   Chalbos Patrick   Bressole Françoise   Ychou Marc  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine/5-FU Combination in Metastatic Breast Cancer Chemotherapy. A Retrospective Study of 63 Cases

By Cany L.   Toulouse C.   Ravaud A.   Durand M.   Mauriac L.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 370-371

Elsevier

Access to resources Recommend Favorite

Colorectal Cancer--Is There an Alternative to 5-FU?

By Bleiberg H.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 536-541

Elsevier

Access to resources Recommend Favorite

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

By Benavides M.   García-Alfonso P.   Cobo M.   Muñoz-Martín A.   Gil-Calle S.   Carabantes F.   Villar E.   Graupera J.   Balcells M.   Pérez-Manga G.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 255-262

Humana Press, Inc

Access to resources Recommend Favorite